<p>Additional fee applies and pre-registration is required.<p>
Launching a private practice demands more than clinical expertise—it requires strategic foresight, legal and financial literacy, and operational rigor. This session provides a comprehensive roadmap from concept to launch, guiding clinicians through entity formation, business planning, compliance setup, and the essential systems that create a foundation for long-term success.

<p>Additional fee applies and pre-registration is required.<p>
Financial management is a core competency for practice sustainability. This session demystifies the financial frameworks behind successful practices, including budgeting, cash flow management, tax strategy, and profitability analysis. Participants will gain actionable insights into aligning clinical goals with financial realities to ensure growth and stability.

<p>Additional fee applies and pre-registration is required.<p>
Understanding payer contracts and credentialing is crucial to maintaining both profitability and compliance. This session breaks down key contract terms, reimbursement structures, and negotiation tactics that protect clinical autonomy and optimize revenue. Attendees will leave better equipped to engage payers with confidence and strategy.

<p>Additional fee applies and pre-registration is required.<p>
AI and automation are rapidly redefining how private practices operate—from documentation and scheduling to analytics and patient engagement. This session explores how to assess, select, and implement technology safely and efficiently, with emphasis on HIPAA compliance, data security, and ROI. Attendees will gain clarity on how to leverage AI to enhance care while reducing administrative burden.

<p>Additional fee applies and pre-registration is required.<p>
Every clinician-entrepreneur must anticipate and mitigate risk from day one. This session explores malpractice exposure, informed consent, documentation best practices, and liability protection strategies. Legal and risk management experts will share real-world examples of how proactive policies can safeguard both patient care and professional reputation.

<p>Additional fee applies and pre-registration is required.<p>
Building the right team is essential to any thriving practice. This session covers recruitment strategy, staff retention, compensation models, and legally sound termination practices. Experts will outline practical HR frameworks tailored for small-to-medium private practices, helping clinicians create compliant, high-performing workplace cultures.

<p>Additional fee applies and pre-registration is required.<p>
In today’s digital-first world, visibility drives viability. This session provides a tactical guide to building and maintaining a patient pipeline through SEO, digital branding, and professional referral networks. Attendees will learn practical methods to enhance online discoverability, reputation management, and long-term referral partnerships.

You don’t want to miss this engaging conference kick off. Our Conference Co-Chairs will provide insight into what you can expect to gain out of attending the conference. Hear about all the great things Psych Congress NP Institute has in store and learn how to get the most out of your conference experience.

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Discover the intricate world of neurobiology. In this session, expert faculty will discuss neurotransmitters, their functions, and their roles in neurological and psychiatric disorders, Delve into neural networks, their adaptability, and how they process information and learn how imbalances in these systems contribute to conditions like depression and schizophrenia. This fundamental review will lay the groundwork and ensure that you can make the most out of your NP Institute experience.

Antidepressants are the most commonly prescribed psychiatric drug class, with a variety of options on the market with differing indications, including depression, anxiety, and more. It is important prescribers understand the differences between the available options. In this session, expert faculty will explore the psychopharmacology of antidepressants, looking at their mechanism of action, review the list of approved medications within this drug-class, and understand appropriate dosing and adverse effects.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career mental health professionals will benefit from these educational grant–supported sessions.

Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Antidepressants are the most commonly prescribed psychiatric drug class, with a variety of options on the market with differing indications, including depression, anxiety, and more. It is important prescribers understand the differences between the available options. In this session, expert faculty will explore the psychopharmacology of antidepressants, looking at their mechanism of action, review the list of approved medications within this drug-class, and understand appropriate dosing and adverse effects.

Explore how telepsychiatry has redefined access, engagement, and continuity of care in psychiatric practice. This session will review recent data on telepsychiatry’s clinical effectiveness for disorders such as depression, anxiety, and bipolar disorder. Faculty will discuss guidelines for virtual psychopharmacologic management, how to conduct effective remote assessments, and strategies to navigate patient safety, confidentiality, and rapport in virtual environments.

Explore the powerful interplay between hormonal changes and psychiatric symptomatology across a woman’s lifespan—from menarche to menopause. This session will examine the psychopharmacologic implications of hormonal fluctuations, including perimenstrual dysphoria, perinatal depression, and menopausal mood shifts. Attendees will review evidence-based strategies to individualize treatment and mitigate relapse risk in hormonally influenced mental illness.

Dinner will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

We invite you to join the Psych Congress NP Institute Steering Committee, staff, select faculty, and your peers for a networking event on Thursday, March 19. This is a wonderful opportunity to meet some of your favorite faculty members. Come join us for some fun at The Water's Edge at the Gaylord Opryland Resort.

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Mood stabilizing medications are used in the treatment of a variety of different psychiatric illnesses including bipolar disorder, depression, and schizoaffective disorders. While there are a number of newer medications within this drug class, some agents such as lithium have been around since the 1940s and still have great clinical effectiveness. In this session, expert faculty will discuss available agents within this medication class, comparing mechanism of action, appropriate dosing, side effect management, and comorbid considerations.

MSLs are a vital part of the scientific chain of communication between clinicians and the pharmaceutical industry. Yet many clinicians do not fully appreciate the wealth of knowledge and information these valuable colleagues bring to us. This session addresses these gaps by exploring the role MSLs play in scientific communication, and how clinicians can best utilize this invaluable source of knowledge.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career mental health professionals will benefit from these educational grant–supported sessions.

Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

With a combined five decades of experience in psychiatric nursing, Andrew and Julie share the essential lessons every early-career mental health professional should know. This practical and empowering session explores how to intentionally shape your professional growth, maintain healthy boundaries with patients and employers, and safeguard your license in an evolving healthcare environment. Attendees will gain strategies for building strong interprofessional relationships, developing a supportive professional network, and cultivating long-term resilience to prevent burnout. Through real-world insights and reflective exercises, participants will leave equipped with a personal roadmap for sustainable, ethical, and fulfilling practice in mental health care.

This session bridges traditional psychopharmacology with the emerging fields of functional, nutritional, and metabolic psychiatry to help clinicians move beyond symptom management and toward lasting recovery. This session explores how root-cause approaches—such as dietary interventions and micronutrient support—can enhance the efficacy of antidepressants and mood stabilizers. Attendees will gain a foundational framework for integrating these evidence-based strategies into practice, with emphasis on personalized care, improved adherence, and expanded treatment options for modern mental health.

Mood stabilizing medications are used in the treatment of a variety of different psychiatric illnesses including bipolar disorder, depression, and schizoaffective disorders. While there are a number of newer medications within this drug class, some agents such as lithium have been around since the 1940s and still have great clinical effectiveness. In this session, expert faculty will discuss available agents within this medication class, comparing mechanism of action, appropriate dosing, side effect management, and comorbid considerations.

Dinner will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Join us for an engaging evening of dessert, cocktails, and cutting-edge clinical conversation with Dr. James Greenblatt, Founder and Chief Medical Officer of Psychiatry Redefined, and a panel of our Fellowship graduates.

This special session offers something refreshingly different—and increasingly essential in today’s clinical landscape. Patients are asking more than ever about supplements, nutrition, metabolic health, and root-cause strategies to support their mental well-being. Nurse Practitioners are often on the front lines of those conversations.

During this interactive program, you’ll be introduced to evidence-based functional, nutritional, and metabolic psychiatry—a practical, clinically relevant model that can be integrated seamlessly into traditional practice. Dr. Greenblatt, a dual-board-certified psychiatrist with more than 30 years of pioneering leadership in nutritional and biological psychiatry, will share real case studies showcasing how integrative approaches can transform patient outcomes.

Our panel of Psychiatry Redefined Fellows will join him for discussion, shared learning, and Q&A—including opportunities to bring forward audience cases for live clinical problem-solving.

It will be an evening of connection, insight, and practical tools you can apply to your practice immediately.

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Antipsychotics are a class of psychotropic medication broadly used to treat not only schizophrenia, but also schizoaffective disorder, bipolar disorder (mania, depression, and maintenance), agitation associated with Alzheimer's dementia, and as an augmentation strategy to treat major depressive disorder. In this session, expert faculty will review all available agents within this medication class, mechanisms of action, appropriate dosing of these agents, and adverse effects.

MSLs are a vital part of the scientific chain of communication between clinicians and the pharmaceutical industry. Yet many clinicians do not fully appreciate the wealth of knowledge and information these valuable colleagues bring to us. This session addresses these gaps by exploring the role MSLs play in scientific communication, and how clinicians can best utilize this invaluable source of knowledge.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career mental health professionals will benefit from these educational grant–supported sessions.

Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Lunch will be served. Seating is limited to 225 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Antipsychotics are a class of psychotropic medication broadly used to treat not only schizophrenia, but also schizoaffective disorder, bipolar disorder (mania, depression, and maintenance), agitation associated with Alzheimer's dementia, and as an augmentation strategy to treat major depressive disorder. In this session, expert faculty will review all available agents within this medication class, mechanisms of action, appropriate dosing of these agents, and adverse effects.

Managing patients with both psychiatric disorders and substance use challenges requires integrated, trauma-informed approaches. This session focuses on treatment planning for patients with dual diagnoses—such as schizophrenia and stimulant use disorder or bipolar disorder and alcohol use. Faculty will review assessment tools, pharmacologic conflicts, and case-based strategies for sequencing treatment and reducing relapse risks in complex clinical presentations.

Artificial intelligence is already reshaping how psychiatric nurse practitioners work—simplifying documentation, enhancing treatment planning, and improving patient monitoring. This session provides a hands-on overview of accessible AI tools that can be implemented in clinical practice now. Learn how to use these technologies to streamline workflow, support clinical decision-making, and elevate patient outcomes—all while maintaining ethical and evidence-based standards.

Accurate coding and documentation are essential for compliance, reimbursement, and recognition of the psychiatric NP’s role in outpatient mental health care. This session offers a clear, practical guide to outpatient CPT coding, documentation standards, and payer expectations—equipping clinicians to reduce denials, improve chart accuracy, and protect the integrity of their clinical work.

Depression treatment is shifting toward rapid-acting interventions that achieve results in hours to days. This session provides an overview of rTMS, ketamine and esketamine, and emerging psychedelic therapies such as psilocybin and MDMA. Attendees will learn the mechanisms of action, metabolism, and safety profiles of these treatments, along with potential drug–drug interactions and practical guidance for clinical use. Emphasis will be placed on translating neurobiologic insights into safe, effective patient care, empowering clinicians to navigate this expanding therapeutic landscape with confidence and precision.

Dinner will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Breakfast will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Prescription stimulants are an effective pharmacotherapeutic choice for the treatment of ADHD, and are frequently prescribed across the lifespan of patients with ADHD. As such, it is important to understand why and how these medications work and react within the body in order to optimize patient care. This session will explore the psychopharmacology of stimulants, looking at their mechanism of action, review the list of approved medications within this category. While prescription stimulants are a strong tool for providers treating ADHD, it is important to understand the alternative forms of care available. Non-stimulant treatment options for ADHD will also be explored.

During this session, our experienced faculty will delve into the advantages of combining psychotherapy and psychopharmacology, revealing how their collaboration can elevate mental health treatment. Ethical dilemmas and potential challenges in this integrated approach will also be discussed, offering clinicians valuable guidance to apply in their practice. Furthermore, you'll have the opportunity to broaden your knowledge of readily available psychotherapy models and training programs, enriching your array of therapeutic resources.

New psychiatric providers often face uncertainty when diagnosing and treating personality disorders due to their complex presentations and stigma. This foundational session is designed to equip with essential clinical skills, frameworks, and confidence to approach personality disorders with competence and compassion. Faculty will review diagnostic criteria, red flags, differential diagnoses, and the basics of therapeutic communication, de-escalation, and appropriate pharmacologic support. Attendees will leave with a practical toolkit to guide initial assessments and management planning, including when to refer and how to avoid common pitfalls in documentation and engagement.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career mental health professionals will benefit from these educational grant–supported sessions.

Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Lunch will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Nurse practitioners are often the first point of contact for children and adolescents in acute psychiatric crisis—yet few feel fully equipped to make high-stakes decisions in these moments. This session offers a focused, case-based approach to clinical decision-making in pediatric psychiatric emergencies, empowering NPs to act confidently and effectively when every minute counts. This session provides a supportive environment for new practitioners to strengthen their skills, learn from experienced pediatric mental health clinicians, and build a foundation for safe, effective psychiatric care.

Delve into the nuances of prescribing for geriatric patients with psychiatric disorders. This session will examine age-related pharmacokinetic and pharmacodynamic changes, polypharmacy challenges, and the safest strategies for using antidepressants, antipsychotics, mood stabilizers, and stimulants in older adults. Attendees will leave equipped to minimize side effects, avoid drug interactions, and tailor pharmacologic plans based on comorbidities and cognitive status.

Join us for the concluding session of the conference as we wrap up four days of education. Our co-chairs will be accompanied by a selection of esteemed faculty members from the event, who will address lingering questions asked throughout the course of the conference.